Johnson & Johnson (JNJ) Finalizes Separation of Kenvue (KVUE), Announces Final Results of Exchange Offer

Go back to Johnson & Johnson (JNJ) Finalizes Separation of Kenvue (KVUE), Announces Final Results of Exchange Offer

Kenvue (KVUE) has a 'compelling relative valuation with approaching catalyst' - Goldman Sachs

August 24, 2023 9:27 AM EDT

Kenvue (NYSE: KVUE) was raised to Buy from Neutral at Goldman Sachs on Thursday, with analyst Jason English maintaining a $29 price target on the stock.

The analyst told investors that a valuation window has opened ahead of a potential share inflection catalyst.... More